Related Experiment Video

Updated: Dec 30, 2025

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.6K

GRK2 enforces androgen receptor dependence in the prostate and prostate tumors

Adam J Adler1, Payal Mittal2,3, Adam T Hagymasi2,4

  • 1Department of Immunology, School of Medicine, UConn Health, Farmington, CT, USA. aadler@uchc.edu.

Oncogene
|January 22, 2020
PubMed

Insights

Loss of GRK2 function accelerates aggressive prostate cancer progression. This study introduces a new mouse model for non-AR-driven prostate cancer, crucial for understanding deadly, therapy-resistant tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastatic prostate cancer resistant to androgen deprivation therapy (ADT) poses a significant clinical challenge.
  • While many recurrent tumors remain androgen receptor (AR)-dependent, non-AR-driven tumors are emerging and associated with poor prognosis.
  • Identifying drivers of aggressive, non-AR-driven prostate cancer is critical for developing new therapeutic strategies.

Purpose of the Study:

  • To develop and characterize a novel genetically engineered mouse model for non-AR-driven prostate cancer.
  • To investigate the role of G protein-coupled receptor kinase 2 (GRK2) as a regulator of AR signaling and prostate cancer progression.
  • To explore the impact of GRK2 downregulation on therapeutic resistance and tumor aggressiveness.

Main Methods:

  • Generation of a transgenic mouse model expressing a dominant-negative GRK2 (GRK2-DN) specifically in the prostate.
  • Assessment of AR and AR target gene expression in prostates with GRK2-DN.
  • Evaluation of castration-induced involution and acceleration of oncogene-initiated prostate tumorigenesis in GRK2-DN mice.
  • Analysis of primary tumor size, metastasis, AR signaling, and neuroendocrine marker expression.

Main Results:

  • Prostate-specific GRK2-DN expression diminished AR and AR target gene expression.
  • GRK2-DN conferred resistance to castration-induced prostate involution.
  • GRK2-DN accelerated oncogene-driven prostate cancer, increasing tumor size and visceral metastasis.
  • GRK2-DN suppressed AR signaling and induced neuroendocrine differentiation markers.

Conclusions:

  • GRK2 plays a crucial role in maintaining AR-dependence in the prostate.
  • Loss of GRK2 function promotes the development of aggressive, non-AR-driven prostate cancer.
  • This mouse model provides a valuable tool for studying and targeting deadly stages of prostate cancer progression.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.7K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
85.4K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K